Loading...
Market
Which research center will be the first to publish a breakthrough in precision cancer surgery funded by the Cancer Moonshot initiative by the end of 2024?
2
Resolution / Starting Odds
Tulane University • 25%
Other funded research center • 25%
None • 25%
Multiple centers simultaneously • 25%
Peer-reviewed publications and official announcements from research centers
Story
Biden Allocates $150 Million for Cancer Moonshot Initiative, Highlights ARPA-H Role in New Orleans
Aug 13, 2024, 08:39 PM
President Joe Biden is dedicating $150 million in federal funding to his 'Cancer Moonshot' initiative, aiming to significantly reduce cancer fatalities in the United States. The funding will be directed towards developing advanced technologies for more effective tumor-removal surgeries, with the goal of cutting U.S. cancer deaths by 50% over the next 25 years. This initiative, launched during the Obama administration and re-launched in 2022, is a personal mission for Biden, whose son Beau died of brain cancer in 2015. The funding will support eight research centers, including Tulane University, to pioneer new methods in precision cancer surgery. The administration recently awarded nearly $9 million to improve access to cancer screenings and follow-up treatments in underserved communities. Biden's efforts are part of a broader strategy to mobilize the entire country in the fight against cancer. The Advanced Research Projects Agency for Health (ARPA-H) is playing a key role in fast-tracking these advancements. Biden and the First Lady announced this funding during their visit to New Orleans.
View original story
Similar markets
Fred Hutch • 25%
Dana-Farber Cancer Institute • 25%
Memorial Sloan Kettering Cancer Center • 25%
Johns Hopkins Kimmel Cancer Center • 25%
Technology development for surgeons • 25%
Cancer screenings • 25%
Follow-up treatments • 25%
Other • 25%
Breast cancer • 25%
Lung cancer • 25%
Prostate cancer • 25%
Other • 25%
AWS • 25%
Deloitte • 25%
Microsoft • 25%
Nvidia • 25%
Stanford University • 25%
Harvard University • 25%
University of California, San Francisco • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
A major pharmaceutical company (e.g., Pfizer, Merck) • 25%
A major tech company (e.g., Google, Microsoft) • 25%
A major hospital network (e.g., Mayo Clinic) • 25%
Other • 25%
California • 25%
New York • 25%
Texas • 25%
Other • 25%
Lymphoma • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Other • 25%
Keck School of Medicine at USC • 25%
Cambridge University • 25%
A Canadian Institution • 25%
Other • 25%